S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
GTHP · GUIDED THERAPEUTICS INC
OTC MARKETS - Real Time Price • USD
$0.19
+0.03
(+18.75%)
● Overnight
DAY'S RANGE
$0.19
$0.15
$0.20
52-WEEK RANGE
$0.19
$0.15
$0.54
What's happening
- GTHP is up 18.75% today, trading at $0.19. — Live quote
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
GTHP
-64.81%
vs S&P 500
-77.86%
1-YEAR RETURN
GTHP
-52.99%
vs S&P 500
-58.47%
6-MONTH RETURN
GTHP
-36.67%
3-MONTH RETURN
GTHP
-34.48%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-01-26 (Q4 2025)
$-0.01
Est. $—
2024-04-26 (Q1 2024)
$-0.01
Est. $—
2023-10-26 (Q3 2023)
$-0.01
Est. $—
2002-07-26 (Q2 2002)
$-18560000.00
Est. $-18931200.00
BEAT +2.0%
Valuation Measures & Ratios
Enterprise Value4$20.4M
Forward P/E5—
PEG Ratio6-3.16
Price / Sales (TTM1)23.91
Price / Book782.05
EV4 / Revenue26.64
EV4 / EBITDA—
Profit Margin-361.28%
Operating Margin-310.17%
Return on Equity (ROE8)-471.48%
Return on Assets (ROA9)-243.93%
Avg Volume (3M)26,270
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short3,727
Change from Prior Settlement-45.37%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 50.3% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-08-13; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -361.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -53.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on GTHP
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $60.0K | $117.0K | $0 | $0 | $0 | $6.0K |
| Gross profit | $0 | $0 | $35.0K | $79.0K | $0 | $0 | $0 | $4.0K |
| Operating income | -$478.0K | -$302.0K | -$485.0K | -$763.0K | -$414.0K | -$561.0K | -$655.0K | -$359.0K |
| Net income | -$605.0K | -$500.0K | -$742.0K | -$811.0K | -$427.0K | -$654.0K | -$709.0K | -$402 |
| EPS (diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| EPS (basic) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Operating margin | — | — | -$808 | -$652 | — | — | — | -$6.0K |
| Net margin | — | — | -$1.2K | -$693 | — | — | — | -$7 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.2M | $1.6M | $1.3M | $903.0K | $940.0K | $967.0K | $1.4M | $1.2M |
| Total liabilities | $7.0M | $6.8M | $7.3M | $6.5M | $6.4M | $6.0M | $6.3M | $6.2M |
| Stockholders' equity | -$5.8M | -$5.2M | -$6.0M | -$5.6M | -$5.5M | -$5.0M | -$4.9M | -$4.9M |
| Total current assets | $527.0K | $911.0K | $605.0K | $799.0K | $811.0K | $811.0K | $1.2M | $1.0M |
| Total current liabilities | $6.2M | $6.0M | $6.6M | $6.5M | $6.4M | $5.9M | $6.2M | $6.0M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Accounts receivable | $4.0K | $4.0K | $4.0K | $6.0K | $8.0K | $2.0K | $3.0K | $2.0K |
| Inventory | $500.0K | $469.0K | $448.0K | $583.0K | $595.0K | $633.0K | $633.0K | $636.0K |
| Other current assets | $11.0K | $69.0K | $90.0K | $123.0K | $23.0K | $61.0K | $173.0K | $211.0K |
| Property, plant & equipment | $11.0K | $13.0K | $16.0K | $18.0K | $18.0K | $21.0K | $23.0K | $25.0K |
| Other non-current assets | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K |
| Accounts payable | $2.3M | $2.3M | $2.4M | $2.4M | $2.3M | $2.2M | $2.1M | $2.1M |
| Accrued liabilities | $1.2M | $1.1M | $1.2M | $952.0K | $1.1M | $1.1M | $1.0M | $923.0K |
| Deferred revenue (current) | $189.0K | $189.0K | $189.0K | $689.0K | $679.0K | $670.0K | $849.0K | $748.0K |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | $53.0K | $91.0K | — | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.4M |
| Retained earnings | -$158.7M | -$158.1M | -$157.1M | -$155.8M | -$155.0M | -$154.2M | -$153.7M | -$153.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$319.0K | -$617.0K | -$291.0K | -$277.0K | -$169.0K | -$331.0K | -$332.0K | -$473.0K |
| Investing cash flow | — | — | $0 | -$2.0K | — | — | $0 | $0 |
| Financing cash flow | -$38.0K | $923.0K | $267.0K | $181.0K | $239.0K | $58.0K | $526.0K | $392.0K |
| Free cash flow | — | — | -$291.0K | -$279.0K | — | — | -$332.0K | -$473.0K |
| Capital expenditures | — | — | $0 | $2.0K | — | — | $0 | $0 |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $11.0K | $68.0K | $25.0K | $22.0K | $311.0K | $19.0K | -$13.0K | $73.0K |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $0 | $0 | $0 | $0 | $8.0K | -$1.0K | -$2.0K | $0 |
| Change in inventory | $31.0K | $21.0K | -$135.0K | -$12.0K | -$38.0K | $0 | -$3.0K | $4.0K |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $767.0K | $7.0K | $98.0K | $13.0K | $81.0K |
| Gross profit | $571.0K | $2.0K | $36.0K | -$68.0K | $20.0K |
| Operating income | -$2.4M | -$2.1M | -$3.5M | -$3.3M | -$2.4M |
| Net income | -$3.2M | -$2.4M | -$3.5M | -$4.3M | -$2.1M |
| EPS (diluted) | $-0.04 | $-0.05 | $-0.07 | $-0.15 | $-0.18 |
| EPS (basic) | $-0.04 | $-0.05 | $-0.07 | $-0.15 | $-0.18 |
| Operating margin | -$309 | -$30.1K | -$3.5K | -$25.6K | -$2.9K |
| Net margin | -$417 | -$34.5K | -$3.6K | -$33.4K | -$2.6K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.3M | $1.4M | $1.7M | $3.4M | $2.0M |
| Total liabilities | $7.3M | $6.3M | $5.5M | $6.2M | $7.5M |
| Stockholders' equity | -$6.0M | -$4.9M | -$3.8M | -$2.9M | -$5.4M |
| Total current assets | $605.0K | $1.2M | $1.4M | $3.0M | $1.6M |
| Total current liabilities | $6.6M | $6.2M | $4.8M | $4.9M | $5.7M |
| Cash & equivalents | — | — | — | $2.3M | $643.0K |
| Accounts receivable | $4.0K | $3.0K | $7.0K | $6.0K | $46.0K |
| Inventory | $448.0K | $633.0K | $632.0K | $548.0K | $571.0K |
| Other current assets | $90.0K | $173.0K | $163.0K | $137.0K | $377.0K |
| Property, plant & equipment | $16.0K | $23.0K | $32.0K | $42.0K | $14.0K |
| Other non-current assets | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K |
| Accounts payable | $2.4M | $2.1M | $2.0M | $2.2M | $2.4M |
| Accrued liabilities | $1.7M | $1.0M | $1.1M | $1.2M | $1.8M |
| Deferred revenue (current) | $189.0K | $849.0K | $424.0K | $509.0K | $337.0K |
| Short-term debt | — | — | $0 | $17.0K | $88.0K |
| Long-term debt | — | — | — | — | $820.0K |
| Common stock & paid-in capital | $3.5M | $3.5M | $3.4M | $3.4M | $3.4M |
| Retained earnings | -$157.1M | -$153.7M | -$151.1M | -$147.4M | -$142.4M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$1.1M | -$1.1M | -$1.7M | -$1.5M | -$1.6M |
| Investing cash flow | -$2.0K | $0 | — | -$31.0K | -$14.0K |
| Financing cash flow | $745.0K | $916.0K | $24.0K | $3.2M | $2.1M |
| Free cash flow | -$1.1M | -$1.1M | -$1.7M | -$1.5M | -$1.6M |
| Capital expenditures | $2.0K | $0 | $0 | $31.0K | $14.0K |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $377.0K | $120.0K | $1.8M | $1.4M | $228.0K |
| Deferred income taxes | $0 | $0 | $0 | $0 | $0 |
| Change in accounts receivable | $7.0K | -$6.0K | $3.0K | -$16.0K | $22.0K |
| Change in inventory | -$185.0K | $1.0K | $84.0K | $58.0K | -$33.0K |
| Change in accounts payable | — | — | — | — | — |
| Debt issued | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding GTHP as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-08-21-05:00 to 2026-03-31-05:00
Recent transactions
- Most recent: Imhoff John E (Reporting person) — Derivative conversion of 157,417 shares on 2026-03-31-05:00.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Imhoff John E | Reporting person | Derivative conversion | 2026-03-31-05:00 | 157,417 |
| Blumberg Richard P. | Reporting person | Other acquisition/disposition | 2026-03-26-05:00 | 56,093 |
| JAMES MICHAEL C | Reporting person | In-the-money option exercise | 2026-02-25-05:00 | 100,000 |
| Grujic Alan | Reporting person | Open market purchase | 2025-08-29-05:00 | 152,108 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-03-31-05:00 | Imhoff John E | Reporting person | Derivative conversion | 157,417 | $0.07 |
| 2026-03-26-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 56,093 | — |
| 2026-03-26-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 260 | — |
| 2026-03-26-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 1,040,000 | — |
| 2026-03-26-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 19,038 | — |
| 2026-03-26-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 88 | — |
| 2026-03-26-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 352,000 | — |
| 2026-03-26-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 2,157 | — |
| 2026-03-26-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 10 | — |
| 2026-03-26-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 40,000 | — |
| 2026-02-27-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 100 | — |
| 2026-02-27-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 400,000 | — |
| 2026-02-27-05:00 | Imhoff John E | Reporting person | Derivative conversion | 156,086 | $0.07 |
| 2026-02-25-05:00 | Blumberg Richard P. | Reporting person | Option exercise | 1,000,000 | — |
| 2026-02-25-05:00 | Imhoff John E | Reporting person | In-the-money option exercise | 500,000 | — |
| 2026-02-25-05:00 | JAMES MICHAEL C | Reporting person | In-the-money option exercise | 100,000 | — |
| 2026-02-02-05:00 | Imhoff John E | Reporting person | Derivative conversion | 312,720 | $0.07 |
| 2026-01-05-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 25,338 | — |
| 2025-12-18-05:00 | Imhoff John E | Reporting person | Derivative conversion | 195,460 | $0.07 |
| 2025-08-29-05:00 | Grujic Alan | Reporting person | Open market purchase | 152,108 | — |
| 2025-08-29-05:00 | Imhoff John E | Reporting person | Open market purchase | 166,667 | $0.18 |
| 2025-08-29-05:00 | JAMES MICHAEL C | Reporting person | Open market purchase | 27,778 | $0.18 |
| 2025-08-21-05:00 | Grujic Alan | Reporting person | Other acquisition/disposition | 17,408 | — |
| 2025-08-21-05:00 | Grujic Alan | Reporting person | Other acquisition/disposition | 50 | — |
| 2025-08-21-05:00 | Grujic Alan | Reporting person | Other acquisition/disposition | 200,000 | — |
| 2025-08-21-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 104,448 | — |
| 2025-08-21-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 300 | — |
| 2025-08-21-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 1,200,000 | — |
| 2025-08-21-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 81,121 | — |
| 2025-08-21-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 233 | — |
| 2025-08-21-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 932,000 | — |
| 2025-04-10-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 165,481 | — |
| 2025-04-10-05:00 | Blumberg Richard P. | Reporting person | Other acquisition/disposition | 55,853 | — |
| 2025-04-10-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 6,365 | — |
| 2025-03-18-05:00 | Imhoff John E | Reporting person | Open market purchase | 1,000,000 | $0.10 |
| 2025-03-18-05:00 | Imhoff John E | Reporting person | Open market purchase | 263,069 | $0.10 |
| 2025-03-18-05:00 | JAMES MICHAEL C | Reporting person | Open market purchase | 150,000 | $0.10 |
| 2025-03-18-05:00 | JAMES MICHAEL C | Reporting person | Open market purchase | 262,945 | $0.10 |
| 2025-03-11-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 286 | — |
| 2025-03-11-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 2,258,690 | $0.13 |
| 2025-03-07-05:00 | Imhoff John E | Reporting person | Open market purchase | 286 | — |
| 2025-03-06-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 300 | — |
| 2025-03-06-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 900,000 | — |
| 2025-03-06-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 2,401 | — |
| 2025-03-06-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 4,801,500 | $0.50 |
| 2025-01-17-05:00 | Imhoff John E | Reporting person | Other acquisition/disposition | 35,312 | — |
| 2024-12-18-05:00 | Imhoff John E | Reporting person | Open market purchase | 1,615,385 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:38 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-05-15 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-05 | 4 | 2026-02-25 | View on SEC.gov → |
| 2026-04-07 | 4 | 2026-03-10 | View on SEC.gov → |
| 2026-04-07 | 4 | 2026-03-10 | View on SEC.gov → |
| 2026-04-07 | 4 | 2026-03-10 | View on SEC.gov → |
| 2026-03-31 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-03-12 | 4 | 2025-12-18 | View on SEC.gov → |
| 2026-03-10 | 8-K | 2026-03-02 | View on SEC.gov → |
| 2026-03-04 | 4 | 2026-02-25 | View on SEC.gov → |
| 2025-11-13 | 10-Q | 2025-09-30 | View on SEC.gov → |
| 2025-09-05 | 4 | 2025-08-21 | View on SEC.gov → |
Recent news
Headlines about GTHP (GUIDED THERAPEUTICS INC). Links open the publisher — we don’t host full articles.
-
Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer
Yahoo Finance · 2026-09-09 -
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
Yahoo Finance · 2026-07-22 -
Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation
Yahoo Finance · 2026-07-14 -
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
Yahoo Finance · 2026-06-16 -
Guided signs agreement to begin clinical trial of cervical cancer detection system
Seeking Alpha · 2022-12-21
No headlines in this category right now — try “All”.